Ruboxistaurin Completed Phase 2 Trials for Diabetic Nephropathy Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00044148The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes